Financial Daily from THE HINDU group of publications
Saturday, May 07, 2005
Financial Daily from THE HINDU group of publications Saturday, May 07, 2005 |
|
|
|
|
|
Agri-Biz & Commodities
-
Research & Development Icrisat releases pigeonpea strain resistant to virus Our Bureau
Hyderabad , May 6 ICRISAT's pigeonpea variety ICP 7035, claimed to be highly resistant to pigeonpea sterility mosaic virus (PPSMV), has been recommended for release at the recent Zonal Research and Extension Advisory Council meeting at the University of Agriculture Sciences, (UAS) Bangalore. The release of ICP 7035 is a joint effort of the research led by the International Crop Research Institute for Semi-Arid Tropics (ICRISAT), Patancheru, and UAS supported by the Department for International Development (DFID), UK. According to Dr William Dar, Director General of ICRISAT, the ICP 7035 would significantly help farmers, especially in sterility mosaic disease (SMD) hotspots. Varieties like ICP 7035 can prevent loss and thereby enhance income to the pigeonpea farmers. Pigeonpea, also known as red gram or arhar, is a major pulse crop and an important protein supplement in the vegetarian diet. Karnataka, one of the largest producers of pigeonpea, is a hotspot of PPSMV infection, which results in sterility mosaic disease (SMD), also regarded as `green plague' due to its destructive nature. The SMD is estimated to cause an annual loss of around $300 million in India and Nepal alone. The average yield of ICP 7035 ranges between 1,200 to 1,600 kg per. The edible portion of the dried seed contains 19.6 per cent protein, 27.4 per cent dietary fibre and 33 per cent starch.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|